Tower Research Capital (TRC)’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-292
| Closed | -$218 | – | 6006 |
|
2024
Q4 | $218 | Sell |
292
-4,278
| -94% | -$3.19K | ﹤0.01% | 5373 |
|
2024
Q3 | $5.58K | Sell |
4,570
-7,449
| -62% | -$9.09K | ﹤0.01% | 4249 |
|
2024
Q2 | $24.9K | Buy |
12,019
+6,884
| +134% | +$14.3K | ﹤0.01% | 3626 |
|
2024
Q1 | $18.7K | Buy |
5,135
+1,086
| +27% | +$3.96K | ﹤0.01% | 3057 |
|
2023
Q4 | $12.2K | Sell |
4,049
-859
| -18% | -$2.59K | ﹤0.01% | 4069 |
|
2023
Q3 | $10.6K | Buy |
4,908
+2,834
| +137% | +$6.09K | ﹤0.01% | 4096 |
|
2023
Q2 | $11.6K | Sell |
2,074
-10,089
| -83% | -$56.5K | ﹤0.01% | 3932 |
|
2023
Q1 | $74K | Buy |
12,163
+8,211
| +208% | +$50K | ﹤0.01% | 2158 |
|
2022
Q4 | $23K | Sell |
3,952
-5,011
| -56% | -$29.2K | ﹤0.01% | 3017 |
|
2022
Q3 | $49K | Buy |
8,963
+3,753
| +72% | +$20.5K | ﹤0.01% | 3179 |
|
2022
Q2 | $19K | Buy |
5,210
+3,537
| +211% | +$12.9K | ﹤0.01% | 3868 |
|
2022
Q1 | $10K | Sell |
1,673
-2,941
| -64% | -$17.6K | ﹤0.01% | 4370 |
|
2021
Q4 | $52K | Buy |
4,614
+4,234
| +1,114% | +$47.7K | ﹤0.01% | 2736 |
|
2021
Q3 | $7K | Buy |
+380
| New | +$7K | ﹤0.01% | 4688 |
|